Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

By Dani Blum The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.

Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease Mario Tama/Getty The Food and Drug Administration has approved Ozempic to reduce the ...

When it comes to losing fat without extreme exercise, only a few medicines are worth considering. With the innovation in the medical world, physicians are now recommending the Ozempic weight loss ...

The U.S. Food and Drug Administration (FDA) has officially approved Ozempic to help reduce the risk of serious kidney ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

Gradually increased to a maximum dose of 2.0 mg weekly. Common side effects include nausea, vomiting, diarrhea, and constipation. Consult your healthcare provider or the Ozempic medication guide ...

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and ...